Protagonist Therapeutics' partners ought to secure two approvals for blockbuster drugs within the next year. Click here to ...

1 Southwest Jiaotong University, 2 University of Leeds, 3 City University of HongKong, 4 NVIDIA, 5 The University of Cailfornia, Merced, 6 Yonsei University Diffusion models have shown remarkable ...

Sanofi acquires Blueprint Medicines Corporation for $9.1bn, gaining revenue-driving Aykavit and pipeline drug BLU-808 ...

The state, on the other hand, argued that the law doesn't determine what treatments are allowed based on sex or transgender ...